 | • レポートコード：MRC2-11QY07145 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はレーバー遺伝性視神経症治療薬のグローバル市場について調査・分析したレポートです。種類別（エラミプレチド、GS-011、IXC-201、KH-176、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別レーバー遺伝性視神経症治療薬の競争状況、市場シェア ・世界のレーバー遺伝性視神経症治療薬市場：種類別市場規模 2015年-2020年（エラミプレチド、GS-011、IXC-201、KH-176、その他） ・世界のレーバー遺伝性視神経症治療薬市場：種類別市場規模予測 2021年-2026年（エラミプレチド、GS-011、IXC-201、KH-176、その他） ・世界のレーバー遺伝性視神経症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のレーバー遺伝性視神経症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のレーバー遺伝性視神経症治療薬市場分析：米国、カナダ ・ヨーロッパのレーバー遺伝性視神経症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのレーバー遺伝性視神経症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のレーバー遺伝性視神経症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのレーバー遺伝性視神経症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alkeus Pharmaceuticals, Inc.、Biovista Inc.、GenSight Biologics S.A.、Ixchel Pharma, LLC、Khondrion BV、Spark Therapeutics, Inc.、Stealth BioTherapeutics Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Leber’s Hereditary Optic Neuropathy Drug Market
The global Leber’s Hereditary Optic Neuropathy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Leber’s Hereditary Optic Neuropathy Drug Scope and Market Size
Leber’s Hereditary Optic Neuropathy Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leber’s Hereditary Optic Neuropathy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Leber’s Hereditary Optic Neuropathy Drug market is segmented into
Elamipretide
GS-011
IXC-201
KH-176
Others
Segment by Application, the Leber’s Hereditary Optic Neuropathy Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Leber’s Hereditary Optic Neuropathy Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Leber’s Hereditary Optic Neuropathy Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Leber’s Hereditary Optic Neuropathy Drug Market Share Analysis
Leber’s Hereditary Optic Neuropathy Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Leber’s Hereditary Optic Neuropathy Drug business, the date to enter into the Leber’s Hereditary Optic Neuropathy Drug market, Leber’s Hereditary Optic Neuropathy Drug product introduction, recent developments, etc.
The major vendors covered:
Alkeus Pharmaceuticals, Inc.
Biovista Inc.
GenSight Biologics S.A.
Ixchel Pharma, LLC
Khondrion BV
Spark Therapeutics, Inc.
Stealth BioTherapeutics Inc.
…
1 Study Coverage
1.1 Leber’s Hereditary Optic Neuropathy Drug Product Introduction
1.2 Market Segments
1.3 Key Leber’s Hereditary Optic Neuropathy Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Size Growth Rate by Type
1.4.2 Elamipretide
1.4.3 GS-011
1.4.4 IXC-201
1.4.5 KH-176
1.4.6 Others
1.5 Market by Application
1.5.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Size, Estimates and Forecasts
2.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Revenue 2015-2026
2.1.2 Global Leber’s Hereditary Optic Neuropathy Drug Sales 2015-2026
2.2 Global Leber’s Hereditary Optic Neuropathy Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Leber’s Hereditary Optic Neuropathy Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Leber’s Hereditary Optic Neuropathy Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Leber’s Hereditary Optic Neuropathy Drug Competitor Landscape by Players
3.1 Leber’s Hereditary Optic Neuropathy Drug Sales by Manufacturers
3.1.1 Leber’s Hereditary Optic Neuropathy Drug Sales by Manufacturers (2015-2020)
3.1.2 Leber’s Hereditary Optic Neuropathy Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Leber’s Hereditary Optic Neuropathy Drug Revenue by Manufacturers
3.2.1 Leber’s Hereditary Optic Neuropathy Drug Revenue by Manufacturers (2015-2020)
3.2.2 Leber’s Hereditary Optic Neuropathy Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Leber’s Hereditary Optic Neuropathy Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Leber’s Hereditary Optic Neuropathy Drug Revenue in 2019
3.2.5 Global Leber’s Hereditary Optic Neuropathy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Leber’s Hereditary Optic Neuropathy Drug Price by Manufacturers
3.4 Leber’s Hereditary Optic Neuropathy Drug Manufacturing Base Distribution, Product Types
3.4.1 Leber’s Hereditary Optic Neuropathy Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Leber’s Hereditary Optic Neuropathy Drug Product Type
3.4.3 Date of International Manufacturers Enter into Leber’s Hereditary Optic Neuropathy Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Size by Type (2015-2020)
4.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales by Type (2015-2020)
4.1.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Type (2015-2020)
4.1.3 Leber’s Hereditary Optic Neuropathy Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast by Type (2021-2026)
4.2.3 Leber’s Hereditary Optic Neuropathy Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Leber’s Hereditary Optic Neuropathy Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Size by Application (2015-2020)
5.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales by Application (2015-2020)
5.1.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Application (2015-2020)
5.1.3 Leber’s Hereditary Optic Neuropathy Drug Price by Application (2015-2020)
5.2 Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Leber’s Hereditary Optic Neuropathy Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Leber’s Hereditary Optic Neuropathy Drug by Country
6.1.1 North America Leber’s Hereditary Optic Neuropathy Drug Sales by Country
6.1.2 North America Leber’s Hereditary Optic Neuropathy Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Type
6.3 North America Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Leber’s Hereditary Optic Neuropathy Drug by Country
7.1.1 Europe Leber’s Hereditary Optic Neuropathy Drug Sales by Country
7.1.2 Europe Leber’s Hereditary Optic Neuropathy Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Type
7.3 Europe Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Leber’s Hereditary Optic Neuropathy Drug by Region
8.1.1 Asia Pacific Leber’s Hereditary Optic Neuropathy Drug Sales by Region
8.1.2 Asia Pacific Leber’s Hereditary Optic Neuropathy Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Type
8.3 Asia Pacific Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Leber’s Hereditary Optic Neuropathy Drug by Country
9.1.1 Latin America Leber’s Hereditary Optic Neuropathy Drug Sales by Country
9.1.2 Latin America Leber’s Hereditary Optic Neuropathy Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Type
9.3 Central & South America Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug by Country
10.1.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug Sales by Country
10.1.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Type
10.3 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Alkeus Pharmaceuticals, Inc.
11.1.1 Alkeus Pharmaceuticals, Inc. Corporation Information
11.1.2 Alkeus Pharmaceuticals, Inc. Description and Business Overview
11.1.3 Alkeus Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alkeus Pharmaceuticals, Inc. Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.1.5 Alkeus Pharmaceuticals, Inc. Related Developments
11.2 Biovista Inc.
11.2.1 Biovista Inc. Corporation Information
11.2.2 Biovista Inc. Description and Business Overview
11.2.3 Biovista Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biovista Inc. Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.2.5 Biovista Inc. Related Developments
11.3 GenSight Biologics S.A.
11.3.1 GenSight Biologics S.A. Corporation Information
11.3.2 GenSight Biologics S.A. Description and Business Overview
11.3.3 GenSight Biologics S.A. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GenSight Biologics S.A. Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.3.5 GenSight Biologics S.A. Related Developments
11.4 Ixchel Pharma, LLC
11.4.1 Ixchel Pharma, LLC Corporation Information
11.4.2 Ixchel Pharma, LLC Description and Business Overview
11.4.3 Ixchel Pharma, LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ixchel Pharma, LLC Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.4.5 Ixchel Pharma, LLC Related Developments
11.5 Khondrion BV
11.5.1 Khondrion BV Corporation Information
11.5.2 Khondrion BV Description and Business Overview
11.5.3 Khondrion BV Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Khondrion BV Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.5.5 Khondrion BV Related Developments
11.6 Spark Therapeutics, Inc.
11.6.1 Spark Therapeutics, Inc. Corporation Information
11.6.2 Spark Therapeutics, Inc. Description and Business Overview
11.6.3 Spark Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Spark Therapeutics, Inc. Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.6.5 Spark Therapeutics, Inc. Related Developments
11.7 Stealth BioTherapeutics Inc.
11.7.1 Stealth BioTherapeutics Inc. Corporation Information
11.7.2 Stealth BioTherapeutics Inc. Description and Business Overview
11.7.3 Stealth BioTherapeutics Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Stealth BioTherapeutics Inc. Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.7.5 Stealth BioTherapeutics Inc. Related Developments
11.1 Alkeus Pharmaceuticals, Inc.
11.1.1 Alkeus Pharmaceuticals, Inc. Corporation Information
11.1.2 Alkeus Pharmaceuticals, Inc. Description and Business Overview
11.1.3 Alkeus Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alkeus Pharmaceuticals, Inc. Leber’s Hereditary Optic Neuropathy Drug Products Offered
11.1.5 Alkeus Pharmaceuticals, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Leber’s Hereditary Optic Neuropathy Drug Market Estimates and Projections by Region
12.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast by Regions 2021-2026
12.2 North America Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast (2021-2026)
12.2.1 North America: Leber’s Hereditary Optic Neuropathy Drug Sales Forecast (2021-2026)
12.2.2 North America: Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast (2021-2026)
12.2.3 North America: Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Leber’s Hereditary Optic Neuropathy Drug Sales Forecast (2021-2026)
12.3.2 Europe: Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Leber’s Hereditary Optic Neuropathy Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Leber’s Hereditary Optic Neuropathy Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Leber’s Hereditary Optic Neuropathy Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Leber’s Hereditary Optic Neuropathy Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Leber’s Hereditary Optic Neuropathy Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Leber’s Hereditary Optic Neuropathy Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Leber’s Hereditary Optic Neuropathy Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Leber's Hereditary Optic Neuropathy Drug Market Segments
Table 2. Ranking of Global Top Leber's Hereditary Optic Neuropathy Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Elamipretide
Table 5. Major Manufacturers of GS-011
Table 6. Major Manufacturers of IXC-201
Table 7. Major Manufacturers of KH-176
Table 8. Major Manufacturers of Others
Table 9. Global Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Leber's Hereditary Optic Neuropathy Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Leber's Hereditary Optic Neuropathy Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Leber's Hereditary Optic Neuropathy Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Leber's Hereditary Optic Neuropathy Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Leber's Hereditary Optic Neuropathy Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Leber's Hereditary Optic Neuropathy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leber's Hereditary Optic Neuropathy Drug as of 2019)
Table 18. Leber's Hereditary Optic Neuropathy Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Leber's Hereditary Optic Neuropathy Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Price (2015-2020) (USD/Pcs)
Table 21. Leber's Hereditary Optic Neuropathy Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Leber's Hereditary Optic Neuropathy Drug Product Type
Table 23. Date of International Manufacturers Enter into Leber's Hereditary Optic Neuropathy Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Leber's Hereditary Optic Neuropathy Drug Sales Share by Type (2015-2020)
Table 27. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Leber's Hereditary Optic Neuropathy Drug Revenue Share by Type (2015-2020)
Table 29. Leber's Hereditary Optic Neuropathy Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Leber's Hereditary Optic Neuropathy Drug Sales Share by Application (2015-2020)
Table 32. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2015-2020)
Table 34. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2015-2020)
Table 38. North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2015-2020)
Table 72. Alkeus Pharmaceuticals, Inc. Corporation Information
Table 73. Alkeus Pharmaceuticals, Inc. Description and Major Businesses
Table 74. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Alkeus Pharmaceuticals, Inc. Product
Table 76. Alkeus Pharmaceuticals, Inc. Recent Development
Table 77. Biovista Inc. Corporation Information
Table 78. Biovista Inc. Description and Major Businesses
Table 79. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Biovista Inc. Product
Table 81. Biovista Inc. Recent Development
Table 82. GenSight Biologics S.A. Corporation Information
Table 83. GenSight Biologics S.A. Description and Major Businesses
Table 84. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. GenSight Biologics S.A. Product
Table 86. GenSight Biologics S.A. Recent Development
Table 87. Ixchel Pharma, LLC Corporation Information
Table 88. Ixchel Pharma, LLC Description and Major Businesses
Table 89. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Ixchel Pharma, LLC Product
Table 91. Ixchel Pharma, LLC Recent Development
Table 92. Khondrion BV Corporation Information
Table 93. Khondrion BV Description and Major Businesses
Table 94. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Khondrion BV Product
Table 96. Khondrion BV Recent Development
Table 97. Spark Therapeutics, Inc. Corporation Information
Table 98. Spark Therapeutics, Inc. Description and Major Businesses
Table 99. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Spark Therapeutics, Inc. Product
Table 101. Spark Therapeutics, Inc. Recent Development
Table 102. Stealth BioTherapeutics Inc. Corporation Information
Table 103. Stealth BioTherapeutics Inc. Description and Major Businesses
Table 104. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Stealth BioTherapeutics Inc. Product
Table 106. Stealth BioTherapeutics Inc. Recent Development
Table 107. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Leber's Hereditary Optic Neuropathy Drug Players
Table 125. Leber's Hereditary Optic Neuropathy Drug Customers List
Table 126. Leber's Hereditary Optic Neuropathy Drug Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Leber's Hereditary Optic Neuropathy Drug Product Picture
Figure 2. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Elamipretide Product Picture
Figure 4. GS-011 Product Picture
Figure 5. IXC-201 Product Picture
Figure 6. KH-176 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Leber's Hereditary Optic Neuropathy Drug Report Years Considered
Figure 13. Global Leber's Hereditary Optic Neuropathy Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Leber's Hereditary Optic Neuropathy Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Leber's Hereditary Optic Neuropathy Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region in 2019
Figure 18. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region in 2019
Figure 20. Global Leber's Hereditary Optic Neuropathy Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Leber's Hereditary Optic Neuropathy Drug Revenue in 2019
Figure 22. Leber's Hereditary Optic Neuropathy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type in 2019
Figure 25. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type in 2019
Figure 27. Global Leber's Hereditary Optic Neuropathy Drug Market Share by Price Range (2015-2020)
Figure 28. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application in 2019
Figure 30. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application in 2019
Figure 32. North America Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2019
Figure 35. North America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Leber's Hereditary Optic Neuropathy Drug Market Share by Type in 2019
Figure 41. North America Leber's Hereditary Optic Neuropathy Drug Market Share by Application in 2019
Figure 42. Europe Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2019
Figure 45. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2019
Figure 46. Germany Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Leber's Hereditary Optic Neuropathy Drug Market Share by Type in 2019
Figure 57. Europe Leber's Hereditary Optic Neuropathy Drug Market Share by Application in 2019
Figure 58. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region in 2019
Figure 62. China Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Market Share by Type in 2019
Figure 85. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Market Share by Application in 2019
Figure 86. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2019
Figure 89. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Leber's Hereditary Optic Neuropathy Drug Market Share by Type in 2019
Figure 97. Latin America Leber's Hereditary Optic Neuropathy Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Market Share by Application in 2019
Figure 110. North America Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
視神経症薬の世界市場（～2026年） Market Analysis and Insights: Global Optic Neuropathy Drug Market The global Optic Neuropathy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Optic Neuropathy Drug Scope and Market Size Optic Neuropathy Drug marke…- 遺伝性血管性浮腫薬の世界市場（～2026年） In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for tr…
- 末梢神経障害治療の世界市場（～2026年） Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology. Market Analysis and Insights: …
- 遺伝性血管浮腫の世界市場（～2026年） Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioede…
- 遺伝性がん検査の世界市場（～2026年） Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation fr…